Sublingual Semaglutide (generic OzempicĀ®) now available! Get Started
Dashboard
Formulas

Clomiphene Citrate 5%/Testosterone 5% Oral Slow Release (MEM4) Capsules

Clomiphene Citrate 5%/Testosterone 5% Oral Slow Release (MEM4) Capsules are specially formulated to provide a controlled and prolonged release of active ingredients, utilizing Methocel E4M, a controlled-release polymer. This formulation is designed to treat conditions such as male hypogonadism and infertility by gradually releasing the medication over an extended period, ensuring sustained therapeutic effects.

The slow-release mechanism reduces dosing frequency and enhances patient compliance, making it an effective option for individuals requiring consistent and prolonged medication delivery. By maintaining stable drug levels in the body, these capsules help manage symptoms associated with the targeted disease states more effectively.

Want a different strength?
Click the Text Us button below.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Must be E-Prescribed
Get Started
Generate LeafletShow Leaflet
This medication requires a prescription from your doctor
Are you a prescriber? Sign Up
Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
Slow Release Capsules
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dosing Calculator

Get general dosing information for a patient by using this calculator.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Formula Information

A small arrow pointing down

The Clomiphene Citrate 5%/Testosterone 5% Oral Slow Release (MEM4) Capsules are a specialized formulation designed to provide a controlled and sustained release of the active ingredients, clomiphene citrate and testosterone. This formulation utilizes Methocel E4M, a high-viscosity hydroxypropyl methylcellulose polymer, which is known for its ability to create a matrix that allows for the gradual release of medication over an extended period. This slow-release mechanism is particularly beneficial for patients requiring consistent therapeutic levels of medication, as it helps maintain stable blood concentrations, reduces the frequency of dosing, and enhances overall patient compliance.

Clomiphene citrate is a selective estrogen receptor modulator (SERM) commonly used to treat conditions such as male hypogonadism and infertility. It works by stimulating the pituitary gland to release more luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn increases the production of testosterone in the testes. Testosterone, a key male hormone, is essential for the development and maintenance of male secondary sexual characteristics, muscle mass, bone density, and overall well-being. By combining clomiphene citrate with testosterone in a slow-release capsule, this formulation aims to optimize hormonal balance and improve symptoms associated with low testosterone levels.

The use of Methocel E4M in these capsules ensures that the active ingredients are released gradually, providing a steady therapeutic effect that can help manage symptoms more effectively than immediate-release formulations. This controlled release is particularly advantageous for patients who may experience fluctuations in hormone levels with traditional dosing methods. By maintaining more consistent hormone levels, patients may experience fewer side effects and improved outcomes in terms of energy levels, mood, libido, and overall quality of life.

For prescribers, this formulation offers a valuable option for patients who require a combination of clomiphene citrate and testosterone therapy. The slow-release nature of the capsules can simplify treatment regimens by reducing the need for multiple daily doses, thereby improving adherence to therapy. Additionally, the controlled release profile may help mitigate the risk of peak-related side effects, providing a more tolerable treatment experience for patients.

Patients considering this formulation should discuss their specific health needs and treatment goals with their healthcare provider to determine if this therapy is appropriate for them. As with any medication, it is important to follow the prescribed dosing schedule and report any adverse effects or concerns to a healthcare professional promptly.

If you have any questions or require further information about Clomiphene Citrate 5%/Testosterone 5% Oral Slow Release (MEM4) Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you with any inquiries you may have.

Drug Interactions

A small arrow pointing down

Clomiphene Citrate 5%/Testosterone 5% Oral Slow Release (MEM4) Capsules are designed to provide a controlled and prolonged release of the active ingredients, clomiphene citrate and testosterone, using Methocel E4M as the controlled-release polymer. This formulation is intended to treat conditions such as male hypogonadism, infertility, and other hormonal imbalances. However, it is crucial to be aware of potential drug interactions that may affect the efficacy and safety of this medication.

Clomiphene citrate, a selective estrogen receptor modulator (SERM), can interact with other medications that influence hormonal pathways. For instance, concurrent use with other SERMs or estrogen-containing medications may lead to an increased risk of adverse effects such as thromboembolic events. Additionally, clomiphene may alter the effectiveness of anticoagulants like warfarin, necessitating close monitoring of INR levels to prevent either bleeding or clotting complications.

Testosterone, an androgen, can interact with a variety of medications. It may enhance the effects of oral anticoagulants, increasing the risk of bleeding. Patients on anticoagulant therapy should be monitored closely, and dose adjustments may be necessary. Testosterone can also interact with insulin and other antidiabetic medications, potentially altering blood glucose levels. Patients with diabetes should monitor their blood sugar levels more frequently and consult their healthcare provider for any necessary adjustments in their diabetes management plan.

Furthermore, testosterone may interact with corticosteroids, potentially exacerbating fluid retention and increasing the risk of edema, particularly in patients with pre-existing cardiovascular conditions. Caution is advised when co-administering these medications, and patients should be monitored for signs of fluid overload. Additionally, testosterone can affect the metabolism of cyclosporine, leading to increased cyclosporine levels and a higher risk of nephrotoxicity. Regular monitoring of cyclosporine levels is recommended to avoid potential toxicity.

Patients and prescribers should also be aware of the potential for interactions with other medications that are metabolized by the liver enzyme CYP3A4, as both clomiphene and testosterone can influence this pathway. Medications that are strong inhibitors or inducers of CYP3A4 may alter the plasma concentrations of clomiphene and testosterone, potentially affecting their therapeutic efficacy and safety profile. It is important to review all medications, including over-the-counter drugs and supplements, with a healthcare provider to identify any potential interactions.

If you have any questions or concerns about the use of Clomiphene Citrate 5%/Testosterone 5% Oral Slow Release (MEM4) Capsules and potential drug interactions, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you with any inquiries you may have.

How Does it Work

A small arrow pointing down

The Clomiphene Citrate 5%/Testosterone 5% Oral Slow Release (MEM4) Capsules are a specialized formulation designed to provide a controlled and sustained release of the active ingredients, clomiphene citrate and testosterone, over an extended period. This formulation utilizes Methocel E4M, a type of controlled-release polymer, which is integral to its slow-release mechanism. Methocel E4M is a hydroxypropyl methylcellulose polymer that swells upon contact with gastrointestinal fluids, forming a gel-like matrix. This matrix gradually releases the encapsulated medication, allowing for a steady diffusion of the active ingredients into the bloodstream. This controlled release profile is particularly beneficial for medications like clomiphene citrate and testosterone, which require consistent plasma levels to achieve optimal therapeutic effects.

Clomiphene citrate is a selective estrogen receptor modulator (SERM) that is commonly used to treat infertility in women by stimulating ovulation. In men, it can be used to treat hypogonadism by increasing the production of endogenous testosterone. Testosterone, on the other hand, is a primary male sex hormone and anabolic steroid that plays a crucial role in the development of male reproductive tissues and the maintenance of secondary sexual characteristics. It is also used in hormone replacement therapy for men with low testosterone levels. The combination of clomiphene citrate and testosterone in a slow-release capsule is designed to address conditions such as male hypogonadism, where maintaining stable testosterone levels is essential for effective treatment.

The slow-release mechanism of the MEM4 capsules offers several advantages for both patients and prescribers. By providing a gradual release of the active ingredients, the formulation helps maintain consistent therapeutic levels in the bloodstream, reducing the peaks and troughs associated with immediate-release formulations. This can lead to improved efficacy and a reduction in side effects, as the body is exposed to a more stable concentration of the medication. Additionally, the extended release profile allows for reduced dosing frequency, which can enhance patient compliance and convenience, particularly for those who may have difficulty adhering to more frequent dosing schedules.

For prescribers, the MEM4 capsules offer a reliable option for managing conditions that benefit from the combined effects of clomiphene citrate and testosterone. The controlled release formulation can be particularly useful in tailoring treatment plans to meet the specific needs of patients, ensuring that they receive the appropriate therapeutic levels of medication over time. This can be especially important in managing chronic conditions where long-term treatment is necessary.

If you have any questions about this formulation or how it may be beneficial for specific conditions, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this or any other compounded medication.

Other Uses

A small arrow pointing down

The formulation of Clomiphene Citrate 5%/Testosterone 5% Oral Slow Release (MEM4) Capsules, designed with Methocel E4M for controlled release, has potential applications beyond traditional therapeutic uses. This combination could be particularly beneficial for individuals who require a tailored approach to hormonal regulation and balance, potentially including off-label uses for managing conditions related to hormonal dysregulation. For instance, some patients and practitioners might explore its application in cases of specific endocrine disorders where conventional treatments haven't been effective or have caused undesirable side effects. The slow-release nature allows for steady hormone levels, which may improve overall treatment outcomes and patient satisfaction.

This formulation could also be explored in optimizing athletic performance, within the parameters of ethical and legal standards, by maintaining balanced testosterone levels, which can support enhanced energy, mood regulation, and overall vitality. Additionally, there could be interest in the application of this compound for older adults experiencing age-related reductions in testosterone levels, aiming to improve quality of life through moderated hormone replacement therapy that minimizes peaks and troughs typical with immediate-release formulations.

Certain research avenues might consider this formulation for investigational purposes to determine its efficacy and safety in addressing metabolic syndrome components, such as insulin resistance and obesity, due to testosterone's potential influence on metabolism. Furthermore, due to the inclusion of clomiphene citrate, this capsule could possibly be considered in the management of male infertility related to low testosterone or hormonal imbalance, providing a controlled therapeutic option to slowly modulate the endocrine system and potentially improve sperm production over time.

The healthcare provider should carefully assess each patient's condition, preferences, and medical history to tailor hormonal therapy accordingly. It's essential for prescribers to remain informed about the specific pharmacokinetics and dynamics involved in the controlled release to guide dosing intervals and manage expectations. Patients should be advised on the unique benefits of slow-release formulations, such as reduced dosing frequency and potential minimization of side effects linked to hormonal fluctuations.

As always, it is important to approach these potential uses within the framework of current clinical guidelines and regulatory statutes governing hormone therapy. Each application should be underpinned with thorough clinical judgement and ongoing monitoring. If you have any questions or require further information, please reach out to us at Bayview Pharmacy.

Frequently Asked Questions

A small arrow pointing down

What are Clomiphene Citrate 5%/Testosterone 5% Oral Slow Release Capsules?

The capsules are a compounded formulation combining Clomiphene Citrate and Testosterone, each at 5% concentration, designed to release the active ingredients gradually over time for sustained therapeutic effects and improved patient compliance.

How does the Oral Slow Release mechanism work in these capsules?

The capsules use Methocel E4M, a controlled-release polymer that allows the encapsulated medication to be released gradually over an extended period, reducing the frequency of dosing and maintaining a consistent therapeutic effect.

What are the benefits of using a controlled-release formulation?

Controlled-release formulations offer sustained therapeutic effects, reduce dosing frequency, enhance patient compliance, and help optimize medication management by maintaining stable drug levels in the bloodstream.

Who might benefit from using Clomiphene Citrate 5%/Testosterone 5% capsules?

Patients who require a combination of Clomiphene Citrate and Testosterone and can benefit from the convenience and sustained release profile of the formulation, potentially including individuals undergoing hormonal therapy, may benefit from these capsules.

Are there any side effects associated with these capsules?

As with any medication, there may be potential side effects, including those associated with Clomiphene Citrate and Testosterone. Patients should consult with their healthcare provider to discuss any concerns or side effects they may experience.

How should these capsules be taken?

The specific dosing regimen should be determined by a healthcare provider, considering the patient's condition and treatment goals. The controlled-release nature allows for less frequent dosing, enhancing convenience and adherence.

Can these capsules be taken with other medications?

Patients should consult their healthcare provider before combining these capsules with other medications to avoid potential interactions and ensure the safe and effective use of their treatment regimen.

What is Methocel E4M, and is it safe?

Methocel E4M is a type of hydroxypropyl methylcellulose used as a controlled-release polymer in pharmaceuticals. It is generally considered safe and is commonly used to provide sustained release of active ingredients in medications.

How long will the effects of these capsules last?

The duration of the effects will depend on individual patient factors, but the slow-release formulation is designed to provide sustained effects over an extended period, reducing the need for frequent doses.

Do these capsules guarantee improved patient compliance?

While the slow-release formulation is designed to enhance compliance by offering sustained effects and less frequent dosing, individual results may vary. Improved compliance also depends on patient-specific factors and adherence to prescribed treatment.

Related Formulas

Related Products
Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.